3rd Quarter - Report

NATIONAL BREAST CANCER COALITION FUND for NATIONAL BREAST CANCER COALITION FUND

Firm
Client
Income
—
Expenses
$60,810
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Funding for the DOD peer-reviewed Breast Cancer Research Program.

LobbyistCovered position, as disclosed
IRENE BUENO New —
LISA GERMAN FOSTER New —
MARGARITA VALDEZ New —
FRANCES M VISCO —

Contacted: SENATE; Defense, Dept of (DOD); Food & Drug Administration (FDA); White House Office; Centers For Disease Control & Prevention (CDC); Defense Advanced Research Projects Agency (DARPA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES

Health Issues HCR

Funding for the DOD peer-reviewed Breast Cancer Research Program; Guaranteed Access to Quality Care for All; Medicaid Breast and Cervical Cancer Treatment Program; Health Care Reform; Issues and legislation related to the Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.

LobbyistCovered position, as disclosed
IRENE BUENO New —
LISA GERMAN FOSTER —
MARGARITA VALDEZ New —
FRANCES M VISCO —

Contacted: Centers For Disease Control & Prevention (CDC); White House Office; SENATE; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Defense, Dept of (DOD); Defense Advanced Research Projects Agency (DARPA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Medical/Disease Research/Clinical Labs MED

Funding for the DOD peer-reviewed Breast Cancer Research Program; Issues and legislation related to the Breast Cancer Deadline 2020 goal of knowing how to end breast cancer by January 1, 2020.

LobbyistCovered position, as disclosed
IRENE BUENO —
LISA GERMAN FOSTER —
MARGARITA VALDEZ New —
FRANCES M VISCO —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; Defense, Dept of (DOD); Natl Institutes of Health (NIH); Defense Advanced Research Projects Agency (DARPA); Centers For Disease Control & Prevention (CDC); SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.